“Kaiser Fast Facts” features “QuickTakes” and “Kaiser Slides” – two tools that provide direct access to facts, data and slides about the nation's health care system and programs, in an easy-to-use format. “QuickTakes” presents an inventory of facts-at-a-glance and "Kaiser Slides" allows Web visitors to freely view, download and print graphics and tables of health policy statistics and trends.

This spotlight examines the public's familiarity with prescription drug advertising, their general opinions of these ads, and their experiences talking to doctors about drugs they saw advertised.  It also explores these topics from the doctors’ point of view. The spotlight compiles and analyzes public opinion data from Kaiser surveys and other sources.

Kaiser Public Opinion Spotlight: Views On Prescription Drugs And The Pharmaceutical Industry

This report describes the U.S. pharmaceutical supply chain, following prescription drugs as they move from manufacturers, to wholesale distributors, to pharmacies, and ultimately to patients. 

This report describes and reviews various options to address prescription drug spending growth, including a description of each cost-containment strategy, its use by private or public payers, and a discussion of known evidence about its effectiveness or cost-saving potential.

The most recent Kaiser Health Poll Report found that Americans believe prescription drugs are improving their lives, but most also say that the drug industry cares more about profits than people. The current report analyzes the new data as well as related polling information from earlier surveys by the Kaiser Family Foundation and other organizations.

Two articles evaluate the impact of direct-to-consumer advertising on the use of antidepressants.

This two-page fact sheet, updated in October 2004, provides trend data for prescription drug expenditures and the key factors that contribute to rising prescription spending: increases in utilization and prices, and changes in drug use from older drugs to newer higher-priced drugs.

This paper looks at how formulary designs and other cost-management tools may affect Medicare beneficiaries’ access to medications through their prescription drug plans.

This annual survey of employers provides detailed insights into trends in employer-based health coverage, including changes in premiums, employee contributions, cost-sharing policies and other relevant information.  The 2004 survey included 3,017 randomly selected public and private firms with three or more employees and was conducted jointly by the Kaiser Family Foundation and the Health Research and Educational.